Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Clinical trial NCT05269329 · COMPLETED

Trial details

NCT number: NCT05269329
Sponsor: Valenta Pharm JSC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Common Cold Acute Respiratory Infection Influenza, Human

Start date: 2021-04-26
Primary completion: 2021-10-26
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.